Eden Research plc

December 15, 2010 04:25 ET

Co-encapsulation development agreements

                                                                                      15 December 2010
                                           EDEN RESEARCH PLC
                                         ("Eden" or "Company")

                                Co-encapsulation development agreements

Eden  Research plc, a leading UK agrochemical development company, is pleased to announce that it  has
signed  two  development  agreements with leading French agrochemical business  SBM  Developpement  SA
("SBM"), based in Lyon. The agreements grant SBM the rights to use Eden's terpene encapsulation system
to co-encapsulate two of SBM's important crop protection molecules with blends of synergistic terpenes
to  create new products that will exhibit a wider spectrum of activity and be less prone to resistance

Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology  for  agricultural  and  non-agricultural  uses  through  appropriate  regional  or  global

Recently,  Eden has been exploring how its platform technology patents and expertise can  be  used  to
enhance the activity of other companies' active ingredients used in crop protection and this agreement
is  the  first of those to be signed. This means that Eden's encapsulation technology can reach  wider
markets  where  products  are already being sold, not just with its own proprietary  formulations  and

SBM  has  two  facilities in France; at Marseille and Beziers, where it manufactures  crop  protection
products  for  a  wide  range of multi-national contract customers, as well  as  its  own  ranges  for
agriculture and hobby gardening applications.

Clive  Newitt,  Managing Director of Eden Research plc said, "We are delighted to be cooperating  with
SBM  on  the  development of our technology incorporating their active ingredients. To date,  we  have
focused on our own proprietary mixtures of terpenes, but with more than 20,000 terpene compounds known
to  exist,  this  type  of  partnership allows our technology to be  exploited  with  minimal  further
expenditure  required  by Eden. We are confident these are the first of many which  will  herald   new
revenue streams for us."

The Directors of Eden are responsible for the contents of this announcement.


Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl


Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk

Contact Information

  • Eden Research plc